High Purity Capecitabine API: Anti-Cancer Raw Material Powder for Advanced Cancers
Discover the critical role of Capecitabine API in modern cancer therapy, offering a potent oral solution for challenging oncological treatments.
Get a Quote & SampleProduct Core Value
Capecitabine API
Capecitabine is a highly effective oral prodrug that selectively transforms into fluorouracil within the body, targeting tumor cells and playing a vital role in treating various advanced cancers. Its unique mechanism of action as an antimetabolite and nucleic acid synthesis inhibitor makes it a cornerstone in chemotherapy regimens.
- Cost effective Capecitabine 154361-50-9: This high-purity API provides a cost-effective solution for pharmaceutical formulations aimed at treating challenging cancers.
- High purity Capecitabine manufacturer: Sourcing from a reputable manufacturer ensures the quality and consistency required for potent anti-cancer drugs.
- Advanced gastric cancer treatment Capecitabine: Capecitabine is indicated as a first-line treatment for advanced gastric cancer, often in combination with platinum-based chemotherapy.
- Metastatic breast cancer chemotherapy: This API is crucial for regimens treating metastatic breast cancer, particularly after failure of anthracycline-based chemotherapy.
Key Advantages
Selective Tumor Targeting
The conversion of Capecitabine to its active form, fluorouracil, is facilitated by enzymes that are more concentrated in tumor tissues, leading to a more targeted anti-cancer effect and potentially reduced systemic toxicity.
Improved Patient Compliance
As an oral medication, Capecitabine offers improved patient compliance compared to intravenous chemotherapy, simplifying treatment administration and enhancing the overall therapeutic experience.
Versatile Treatment Applications
From adjuvant treatment of colon cancer to managing metastatic breast and gastric cancers, Capecitabine's broad application spectrum makes it a versatile component in oncological treatment strategies.
Key Applications
Colorectal Cancer Treatment
Capecitabine is a vital component in the treatment of both adjuvant and metastatic colorectal cancer, offering a proven therapeutic option.
Metastatic Breast Cancer Therapy
It is indicated for patients with metastatic breast cancer, particularly those resistant to conventional therapies like anthracyclines and taxanes.
Gastric Cancer Management
Capecitabine is used as a first-line treatment for advanced gastric cancer, often in combination regimens, demonstrating its efficacy in gastrointestinal malignancies.
Oncology Drug Development
The high purity of Capecitabine API is essential for research and development in new cancer therapies and combination drug treatments.